Navigation Links
Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
Date:5/6/2013

MOUNTAIN VIEW, Calif., May 6, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Company has been selected to present its AZ-002 (Staccato® alprazolam) program at the Pipeline Session of the Antiepileptic Drug and Device Trials (AED) XII Conference, the premier conference devoted to convening the full spectrum of research, industry and regulatory expertise in the epilepsy field with the objective of accelerating the most promising epilepsy therapies in development.  The three-day AED XII conference will feature clinical and scientific thought leaders addressing antiepileptic drug and medical technology development from preclinical- through late-stage clinical programs.  The conference will take place on May 15-17, 2013 at the Turnberry Isle Miami Hotel, Aventura, Florida.  James V. Cassella , PhD, Alexza Executive Vice President, Research and Development and Chief Scientific Officer will be speaking at 1:45 p.m. Eastern Time on Friday, May 17, 2013.

According to the Epilepsy Foundation, with nearly three million affected in the U.S. alone, epilepsy is as common as breast cancer and almost as prevalent as Alzheimer's disease.

"We are excited that Alexza's AZ-002 product candidate will be highlighted in the Pipeline Session at the AED XII Conference before such a high caliber group of scientific, clinical and industry representatives," said James V. Cassella , PhD.  "Staccato alprazolam is being developed for the treatment of acute repetitive seizures (ARS).  ARS occurs in a small subset of patients with epilepsy who regularly experience breakthrough seizures in flurries or clusters, despite treatment with a regimen of anti-epileptic drugs."

"Now in its twelfth year, the Antiepileptic Drug and
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza to Announce 2012 First Quarter Financial Results on Thursday, May 10, 2012
2. Alexza Receives Complete Response Letter for Adasuve™ NDA
3. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Alexza Pharmaceuticals Inc.
4. Alexza Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
5. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
6. Alexza Announces Management Promotions
7. Alexza Reports 2012 Second Quarter Financial Results and Provides Business Update
8. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
9. Alexza Pharmaceuticals Corporate Presentation to Be Webcast at Three Upcoming Investor Conferences
10. Alexza to Report 2012 Year-End Financial Results on Tuesday, March 26, 2013
11. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... WASHINGTON , July 14, 2014 The ... social experiment – as well as a new economic ... they try to sort out the right response to ... and recreational intoxicant. At a National ... at 10 a.m., two leading experts in the area ...
(Date:7/14/2014)... , July 14, 2014 We are ... Center ("OACM") and the Ellicott City Ambulatory Surgery Center ... Ellicott City Maryland . ... Merritt Healthcare and 14 leading Orthopaedics, Sports Medicine, Hand, ... will also accommodate the specialties of general surgery and ...
(Date:7/14/2014)... , 14 de julio de 2014 /PRNewswire-HISPANIC PR WIRE/ ... que Barry Epling , presidente de la junta ... de la Compañía. El señor Epling es el dueño ... otorgó la licencia de su formulación, sus propiedades intelectuales ... de apoyo financiero. "El señor Gerald ...
Breaking Medicine Technology:NPC Newsmaker Program: Interpreting smoke signals from the marijuana skirmish line 2BioAdaptives se prepara para el próximo paso 2BioAdaptives se prepara para el próximo paso 3
... artery that feeds the heart, the body responds by ... As these so-called collateral,vessels grow more muscular and interconnected, ... the blockage. Scientists have been trying for,years to nudge ... success. However, you can do it at home without ...
... RenalGuard(TM) in preventing ... Contrast -Induced Nephropathy, FRANKLIN, Mass., Dec. ... focused on innovative cardiac and vascular medical,device-based technologies, announced today ... trial of its RenalGuard Therapy(TM).,The lead investigators are Charles Davidson, ...
Cached Medicine Technology:Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes 2PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM) 2PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM) 3PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM) 4
(Date:7/14/2014)... Hicksville and Hauppauge, NY (PRWEB) July 14, 2014 ... York (RGONY), with offices in Hicksville and Hauppauge, ... intravitreal implant) as a long-lasting treatment for diabetic ... by Allergan, recently obtained an additional FDA-approved indication ... previously approved by the FDA in 2009 for ...
(Date:7/14/2014)... 14, 2014 According to a recent ... researchers have discovered a connection between women with high ... of infertility. Although doctors have theorized about the role ... first study to provide scientific support. , “Stress, if ... said Dr. Larry Barmat, an OB/GYN who specializes in ...
(Date:7/14/2014)... Last month Bromell Agency officially launched the ... features more detailed information on how clients can protect ... and boats in the state of Louisiana. , The ... the website in order to better educate clients on ... of the website, which is to display comprehensive insurance ...
(Date:7/14/2014)... 14, 2014 There’s an old adage that ... The Lash Palette say the products offered in their ... , “You can reserve The Lash Palette for $40,” said ... Store . , Paris explained that the first 1,000 have ... 21. , She went on to point out that her ...
(Date:7/14/2014)... 14, 2014 Seven promising startup ... healthcare problems have been accepted into the ... Accelerator (DHA). , The awardees were selected ... multi-stage process. They include Biomeme, Fitly, Life Patch, ... (from France) and Pulse InfoFrame (from Canada) —both ...
Breaking Medicine News(10 mins):Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 2Health News:Retina Group of New York Now Offers Long-lasting Ozurdex® Treatment for Diabetic Retinopathy 3Health News:Abington Health Physician Addresses Link Between Stress and Infertility 2Health News:Abington Health Physician Addresses Link Between Stress and Infertility 3Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 2Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 3Health News:Seven Healthcare Startups Selected to Participate in University City Science Center’s First Digital Health Accelerator 4
... GHX honored 14 healthcare,provider and supplier organizations with ... The awards were,presented on Friday, April 18, 2008 during ... Supply Chain Summit, the largest healthcare,forum in the U.S. ... the supply,chain., The theme of this year,s awards ...
... elder men and often compresses the urethra resulting in ... way to measure the resistance of the urethra using ... sound spectrum of the recorded sound depends on how ... men with voiding symptoms, such as a weak urinary ...
... market to over $300 million ... according to Millennium Research Group, WALTHAM, Mass., April ... Ultrasound Systems 2008 report, the,emerging ultrasound market will experience ... compound annual growth rate of over 15% from 2007 ...
... team develops simple test to identify those at risk ... quick, self-administered test to identify surgical patients who may ... developed by a team of Canadian anesthesiologists. , ... while they sleep. The disorder affects 2 percent to ...
... ... ... net ... is now expected to be in the range of $5.42 -, $5.67 per share, including net realized investment ...
... to $1.09; ... FRANKLIN LAKES, N.J., April 23 BD (Becton,Dickinson ... quarterly revenues,of $1.747 billion for the second fiscal quarter ... over the prior year period. This,quarter,s revenue growth rate ...
Cached Medicine News:Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 2Health News:GHXcellence Awards Honor Healthcare Providers and Suppliers for Achievements in Supply Chain Performance 3Health News:Emerging Ultrasound Market to Grow Rapidly Over Next Five Years 2Health News:Sleep Apnea Screening Cuts Surgical Complications 2Health News:WellPoint Reports First Quarter 2008 Results 2Health News:WellPoint Reports First Quarter 2008 Results 3Health News:WellPoint Reports First Quarter 2008 Results 4Health News:WellPoint Reports First Quarter 2008 Results 5Health News:WellPoint Reports First Quarter 2008 Results 6Health News:WellPoint Reports First Quarter 2008 Results 7Health News:WellPoint Reports First Quarter 2008 Results 8Health News:WellPoint Reports First Quarter 2008 Results 9Health News:WellPoint Reports First Quarter 2008 Results 10Health News:WellPoint Reports First Quarter 2008 Results 11Health News:WellPoint Reports First Quarter 2008 Results 12Health News:WellPoint Reports First Quarter 2008 Results 13Health News:WellPoint Reports First Quarter 2008 Results 14Health News:WellPoint Reports First Quarter 2008 Results 15Health News:WellPoint Reports First Quarter 2008 Results 16Health News:WellPoint Reports First Quarter 2008 Results 17Health News:BD Announces Results for Second Fiscal Quarter 2Health News:BD Announces Results for Second Fiscal Quarter 3Health News:BD Announces Results for Second Fiscal Quarter 4Health News:BD Announces Results for Second Fiscal Quarter 5Health News:BD Announces Results for Second Fiscal Quarter 6Health News:BD Announces Results for Second Fiscal Quarter 7Health News:BD Announces Results for Second Fiscal Quarter 8Health News:BD Announces Results for Second Fiscal Quarter 9Health News:BD Announces Results for Second Fiscal Quarter 10Health News:BD Announces Results for Second Fiscal Quarter 11Health News:BD Announces Results for Second Fiscal Quarter 12Health News:BD Announces Results for Second Fiscal Quarter 13Health News:BD Announces Results for Second Fiscal Quarter 14Health News:BD Announces Results for Second Fiscal Quarter 15
... an enterprise visibility solution that allows ... effectiveness, and increase patient satisfaction. ... systems and geospatial visual technologies with ... a real time patient care model ...
MONOJECT SUPRA/HONE Blood Collection Needles - Thin Wall...
... are preominantly used for routine blood collection. ... of the needle protective cap simplifies visual ... example, yellow symbolises the needle dimension 20 ... mm) and black 22 G (0.70 mm). ...
ScanGel® Centrifuge...
Medicine Products: